The patient has elective or planned major surgery to be performed during the course of the clinical trial
Major surgery within 4 weeks
Have a planned major surgery.
Elective or planned major surgery to be performed during the course of the trial
Major surgery within 3 weeks of scheduled C1D1 dosing.
Recent major surgery within 4 weeks prior to first infusion
Patients who are less than 4 weeks post-op after major surgery
Major surgery within 2 weeks prior to trial entry;
Patients with elective or planned major surgery to be performed during the course of the clinical trial
Has had major surgery in the past 4 weeks.
Major surgery
Major surgery in the last three weeks
At least 2 weeks must have elapsed since undergoing major surgery
Patients who may require major surgery during the course of the study
At least 3 weeks from major surgery
Major surgery or radiation within 4 weeks prior to study entry
Major surgery: 6 weeks
The patient has elective or planned major surgery to be performed during the course of the clinical trial
All major surgery including prior surgery to the brain within 3 weeks of commencement of study therapy
At least 4 weeks since major surgery or radiation therapy
Any major surgery, as determined by the Investigator, within 4 weeks of IMP administration
Major surgery within 4 weeks before starting study treatment or scheduled for surgery during the projected course of the study
Major surgery: ?2 weeks
Major surgery ? 2 weeks prior to starting CC-90002.
Patients who have had major surgery within 6 weeks prior to the first dose of study drug or have major surgery planned during the first 12 weeks after MT-3724 has finished.
Major surgery (as defined by the Investigator): ?4 weeks
No chemotherapy, radiotherapy, major surgery, or biologic therapy within 3 weeks of protocol treatment
Known bleeding risk including serious hemorrhage or hemoptysis within the last 3 months; major surgery within the past 8 weeks or minor surgery within the past 4 weeks
The participant has electively planned or will require major surgery during the course of the study.
Major surgery within 4 weeks before screening
Major surgery within the past 2 months
Have electively planned or will require major surgery during the course of the study.
< 2 weeks since major surgery (i.e., laparotomy or thoracotomy)
Major surgery performed within 4 weeks of study entry
Major surgery, other than diagnostic surgery, occurring 4 weeks prior to study entry; splenectomy will not be considered an exclusionary major surgery
Had major surgery ? 4 weeks of C1D1
Major surgery within 4 weeks before starting study treatment or scheduled for surgery during the projected course of the study
Major surgery (major according to the Investigator's assessment) performed within 12 weeks prior to first trial treatment or planned within 12 months after screening, e.g.,hip replacement
Received major surgery, radiotherapy, or immunotherapy within 4 weeks of GSK2879552 administration
Major surgery within prior 4 weeks and minor surgery within 7 days;
Major surgery in the last two weeks of starting study therapy; this does not include procedures like biopsy (needle or excisional) or port placement as these are not considered as major surgery
Major surgery without full recovery or major surgery within 3 weeks of screening
The patient has elective or planned major surgery to be performed during the course of the clinical trial
Major surgery within 3 weeks prior to event 1
CAPMATINIB EXCLUSION CRITERIA: Major surgery (e.g., intrathoracic, intraabdominal or intrapelvic) within 4 weeks prior (2 weeks for resection of brain metastases) to starting capmatinib; video-assisted thoracic surgery (VATS) and mediastinoscopy will not be counted as major surgery and patients can be enrolled in the study >= 1 week after the procedure
At least 4 weeks from major surgery
Major surgery within 12 weeks of enrolment
Major surgery within 4 weeks of starting study treatment
The patient has elective or planned major surgery to be performed during the course of the clinical trial
Major surgery within 4 weeks of initiation of therapy; clearance letter from primary physician required
Major surgery within 4 weeks before starting study treatment or scheduled for surgery during the projected course of the study
Major surgery in the past 4 weeks.
A history of any major surgery within 6 weeks prior to dosing
Any major surgery within the last 3 weeks
Patients who have had major surgery within 4 weeks of initiation of study medication
Major surgery in the past 16 weeks
Major surgery within two weeks prior to trial entry
> 4 weeks since major surgery
>= 2 weeks since major surgery
Major surgery, other than diagnostic surgery, within 2 weeks
Planned major surgery
Major surgery within 4 weeks prior to study treatment.
Major surgery in last 4 weeks, minor surgery in the last 2 weeks
Major surgery within 4 weeks prior to starting INC280
Major surgery/surgical therapy for any cause within 4 weeks of Screening;
Elective or planned major surgery to be performed during the course of the trial
Major surgery within 4 weeks prior to study entry
Any major surgery within the last four weeks.
Has received major surgery within the 4 weeks prior to starting the trial.
Any major surgery within the last four weeks.
Major surgery within the last 4 weeks; minor surgery within the last 2 weeks
Major surgery within 4 weeks prior to inclusion
At least 4 weeks must have elapsed since the last chemotherapy, radiotherapy or major surgery
Major surgery within four weeks before first IMP administration.
Planned major surgery during the study
Patients who are less than 4 weeks post-operative (op) after major surgery
No planned major surgery
Planned major surgery
Major surgery without full recovery or major surgery within 3 weeks of Screening.
Minimum of four weeks since any major surgery, completion of radiation
Patients less than 4 weeks post major surgery
Major surgery, other than diagnostic surgery, occurring 4 weeks prior to study entry; splenectomy will not be considered an exclusionary major surgery
Major surgery within 4 weeks prior to the screening visit
Major surgery within 4 weeks prior to screening.
Participants with major surgery in the 4 weeks prior to randomization (Video-assisted thoracoscopic surgery (VATS) and/or mediastinoscopy is not considered major surgery).
Major surgery for any reason, except diagnostic biopsy, within 4 weeks of enrolment and/or if the subject has not fully recovered from the surgery within 4 weeks of enrolment
Subject has had major surgery, other than diagnostic surgery, within 4 weeks prior to treatment in study.
Major surgery </= 4 weeks before study treatment
Major surgery <4 weeks or radiation therapy <2 weeks of patient registration.
Major surgery within 4 weeks before starting study treatment or scheduled for surgery during the projected course of the study
Major surgery for any reason, except diagnostic biopsy, within 4 weeks and/or if the subject has not fully recovered from the surgery within 4 weeks
Major surgery requiring the use of general anesthetic within 4 weeks of study enrollment
Major surgery, other than diagnostic surgery (e.g., surgery done to obtain a biopsy for diagnosis without removal of an organ), within 4 weeks prior to first dose.
Major surgery without full recovery or major surgery within 3 weeks of Screening.
Major surgery within the previous 4 weeks
Severe infection or major surgery within 4 weeks, or oral or IV antibiotics treatment within 2 weeks prior to enrollment
have an elective or a planned major surgery during the course of the trial
Major surgery within 4 weeks of starting trial
Major surgery
Major surgery within 4 weeks of study treatment
Major surgery within 4 weeks
Received major surgery, radiotherapy, or immunotherapy within 4 weeks of GSK2879552 administration.
Recent major surgery
Major surgery within 4 weeks of study treatment
Have a planned major surgery.
Major surgery, other than diagnostic surgery, within 2 weeks
Major surgery within 4 weeks of starting treatment.
Major surgery within 4 weeks of starting the study treatment
Any major surgery within the last 3 weeks
Major surgery within 4 weeks of initiation of therapy
Major surgery within 4 weeks of initiation of therapy
At least 4 weeks since major unrelated surgery, with full recovery
Major surgery within four weeks before initiation of therapy
No major surgery within 2 weeks of starting study treatment
At least 4 weeks must have elapsed from major surgery
No major surgery within 4 weeks prior to study entry
Any major surgery within the last 4 weeks
Subjects who have had major surgery within 4 weeks prior to entering the study
Patients who are within 4 weeks of major surgery or within 2 weeks of minor surgery
Patients must be > 4 weeks from any major surgery
Major surgery within 4 weeks of random assignment
Major surgery within 4 weeks prior to entering the study
Recovery from any major or minor surgeries; patient must be 4 weeks post-major surgery and 2 weeks post-minor surgery
Major surgery within the last 4 weeks; minor surgery within the last 2 weeks
Major surgery within 4 weeks prior to entering the study
Any major surgery or radiation therapy within four weeks.
Patients that may require major surgery during the course of the study
Major surgery within 4 weeks
>= 2 weeks since major surgery
Major surgery, other than diagnostic surgery, within 2 weeks
Patient has had major surgery within the last 3 weeks
Major surgery within 4 weeks of study randomisation.
At least 4 weeks must have elapsed from major surgery
Any major surgery within 4 weeks of starting treatment on protocol
Recent major surgery (within 4 weeks), other than for diagnosis
Major surgery within 4 weeks (or within 2 weeks following consultation with and approval of Medical Monitor)
Major surgery within 4 weeks of screening
Major surgery or irradiation within two weeks
Major surgery or irradiation within two weeks
Elective or a planned major surgery while on study treatment
Major surgery within 4 weeks prior to entry
The participant has a history of major surgery or treatment other cancer therapy within 2-6 weeks before starting the study
Major surgery within 2 weeks
Major surgery within 4 weeks (less than 28 days) prior to C1D1
Major surgery within 4 weeks prior to C1D1
Major surgery within 4 weeks of C1D1
Major surgery within 4 weeks
Major trauma or surgery w/in prior 4 weeks
Major surgery within the last 2 weeks
Major surgery other than diagnostic surgery =< 4 weeks
At least 3 weeks from major surgery with full recovery
No chemotherapy, radiotherapy, major surgery, or biologic therapy within 3 weeks of protocol treatment
Major surgery (as judged by the investigator) within 4 weeks
Major surgery or trauma within 4 weeks
Major surgery within 4 weeks prior to IP administration
Subjects may not have any major surgery within 4 weeks
At least 4 weeks from prior major surgery or radiotherapy
Patients who have had major surgery within 4 weeks of initiation of study medication
Has an elective or planned major surgery to be performed during the course of the trial
Elective or a planned major surgery
At least 4 weeks from prior major surgery or radiotherapy.
Radiotherapy or major surgery within 4 weeks
Major surgery within preceding 8 weeks
Major surgery within the past 2 weeks.
Patient is planning major surgery within the next 6 months
Major surgery within 4 weeks or till recovery to baseline functioning (per patient) whichever is shorter
Major surgery within four weeks before consent date
Major surgery within the past 2 weeks
Undergoing major surgery
Patients who have had major surgery within 4 weeks of initiation of study medication
Any major surgery within the last four weeks.
Major surgery within 2 weeks
Major surgery within 4 weeks prior to C1D1.
A minimum of 4 weeks from any major surgery prior to enrollment; coincident standard of care surgery with the research biopsy is permitted during the study
Major surgery within 4 weeks
Major surgery in the past 8 weeks (Arms 1 and 4)
Any chemotherapy within 4 weeks, or major surgery or radiotherapy within the last 14 days.
Major surgery (eg, laparotomy, thoracotomy or joint replacement) within 3 weeks prior to randomization or elective surgery scheduled to be performed during the study.
